Cargando…

Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand

BACKGROUND: The aim of this study was to assess trends and variations in coprescribing of simvastatin or atorvastatin with interacting drugs in Thailand. METHODS: Outpatient prescriptions between 2013 and 2015 in 26 tertiary care hospitals were analyzed for statin coprescribing. The proportion of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rattanachotphanit, Thananan, Limwattananon, Chulaporn, Waleekhachonloet, Onanong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354302/ https://www.ncbi.nlm.nih.gov/pubmed/30728944 http://dx.doi.org/10.1177/2042098618820502

Ejemplares similares

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2019)

Effects of a national policy advocating rational drug use on decreases in outpatient antibiotic prescribing rates in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2021)

Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand
por: Limwattananon, Chulaporn, et al.
Publicado: (2019)

Budget impact analysis of the new reimbursement policy for day surgery in Thailand
por: Suphanchaimat, Rapeepong, et al.
Publicado: (2019)

Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand
por: Limwattananon, Chulaporn, et al.
Publicado: (2020)

Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018)

Atorvastatin and simvastatin as analgesic agents in experimental models
por: Dwajani, S., et al.
Publicado: (2012)

Adherence to coprescribing of laxatives with opioids and associated characteristics in general practices in the Netherlands
por: Hek, Karin, et al.
Publicado: (2022)

Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013)

Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin
por: Jaiswal, Swapnil R., et al.
Publicado: (2012)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
por: Sivkov, Andrey, et al.
Publicado: (2021)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?
por: Penner, Leonie S., et al.
Publicado: (2022)

CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand
por: Cha’on, Ubon, et al.
Publicado: (2020)

CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2015)

Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016
por: Jeffery, Molly M., et al.
Publicado: (2019)

Childhood stunting in Thailand: when prolonged breastfeeding interacts with household poverty
por: Cetthakrikul, Nisachol, et al.
Publicado: (2018)

Landscape change trends and their impacts on coastal tourism resources in the future: a case study from pak Phanang, Thailand
por: Cheablam, Onanong, et al.
Publicado: (2022)

Evaluation of Sexual Dimorphism in the Efficacy and Safety of Simvastatin/Atorvastatin Therapy in a Southern Brazilian Cohort
por: Smiderle, Lisiane, et al.
Publicado: (2014)

Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs
por: Henriksson, Kenneth, et al.
Publicado: (2014)

The role of managed care pharmacy in coprescribing naloxone for patients with specific risk: recommendations from the AMCP Addiction Advisory Group
por: Skelton, Jann B, et al.
Publicado: (2022)

A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations
por: Alhazmi, Hassan A., et al.
Publicado: (2017)

Disparate Effects of Atorvastatin Compared With Simvastatin on C-Reactive Protein Concentrations in Patients With Type 2 Diabetes
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort
por: Clarke, Alan T., et al.
Publicado: (2016)

Monitoring and Evaluating Progress towards Universal Health Coverage in Thailand
por: Tangcharoensathien, Viroj, et al.
Publicado: (2014)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
por: Gandhi, Sanjay K, et al.
Publicado: (2012)

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
por: Insull, William, et al.
Publicado: (2010)

Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern
por: Eliasson, Pernilla, et al.
Publicado: (2017)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Similar Medication Compliance and Control of Dyslipidemia WithSimvastatin or Atorvastatin in a Staff-Model HMO Medical Clinic
por: Valdez, Connie A., et al.
Publicado: (2005)

Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice
por: Ding, Yan, et al.
Publicado: (2023)

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis
por: Lee, Eun Bong, et al.
Publicado: (2016)

Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre
por: Tilli, Tiana, et al.
Publicado: (2020)

Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings
por: Suvada, Kara, et al.
Publicado: (2022)

In vivo and In vitro Drug Interactions Study of Glimepride with Atorvastatin and Rosuvastatin
por: Galani, VJ, et al.
Publicado: (2010)

Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone
por: Elazzazy, Shereen, et al.
Publicado: (2012)

Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Sequential Cohort Design Applying Propensity Score Matching to Analyze the Comparative Effectiveness of Atorvastatin and Simvastatin in Preventing Cardiovascular Events
por: Helin-Salmivaara, Arja, et al.
Publicado: (2014)

Effect of Simvastatin and Atorvastatin on Serum Vitamin D and Bone Mineral Density in Hypercholesterolemic Patients: A Cross-Sectional Study
por: Thabit, K. Abrar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gsthnets7hv0b1vgs2v4s9mbhp